Disease progression in LRRK2 parkinsonism.

doi:10.1016/S1474-4422(17)30082-0

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Disease progression in LRRK2 parkinsonism.

The Lancet. Neurology - 1 May 2017

Politis Marios

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Genetic Predisposition to Disease
Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Parkinson Disease

Share to Parkinsonian Disorders

Source

Open in PubMed

Identifiers

PMID: 28414642
DOI: 10.1016/S1474-4422(17)30082-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disease progression in LRRK2 parkinsonism.PMID 28414642Read ↗

LRRK2 inhibitor progresses for Parkinson disease.Semantic proximity Read ↗

LRRK2 in Parkinson disease: challenges of clinical trialsSemantic proximity Read ↗

Genetics of Parkinson's disease: LRRK2 on the rise.Semantic proximity Read ↗

Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review.Semantic proximity Read ↗

Recent Developments in LRRK2-Targeted Therapy for Parkinson’s DiseaseSemantic proximity Read ↗

Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's diseaseSemantic proximity Read ↗

[Pathogenesis of Parkinson's disease through LRRK2 mutation].Semantic proximity Read ↗

PARK8 LRRK2 parkinsonism.Semantic proximity Read ↗

LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?Semantic proximity Read ↗

The pleomorphic pathology of inherited Parkinson's disease: lessons from LRRK2.Semantic proximity Read ↗

Progression in the LRRK2-Asssociated Parkinson Disease Population.Semantic proximity Read ↗

LRRK2-targeted Parkinson disease drug advances into phase IIISemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.